Akoya Biosciences Inc
NASDAQ:AKYA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Akoya Biosciences Inc
NASDAQ:AKYA
|
US |
|
A
|
Aristocrat Leisure Ltd
SWB:AC8
|
AU |
|
I
|
Interpublic Group of Companies Inc
DUS:IPG
|
US |
|
M
|
Msg Life Ag
XHAM:MSGL
|
DE |
|
Giga Media Ltd
NASDAQ:GIGM
|
TW |
|
Advanced Media Inc
TSE:3773
|
JP |
|
Motio Ltd
ASX:MXO
|
AU |
|
P
|
Port of Tauranga Ltd
NZX:POT
|
NZ |
|
PSP Swiss Property AG
F:P7S
|
CH |
|
N
|
New York Community Bancorp Inc
F:QC1
|
US |
|
IHI Corp
TSE:7013
|
JP |
|
Lu Hai Holding Corp
TWSE:2115
|
TW |
|
Community Trust Bancorp Inc
NASDAQ:CTBI
|
US |
|
Organto Foods Inc
XTSX:OGO
|
CA |
|
L
|
LYC Healthcare Bhd
KLSE:LYC
|
MY |
|
COSCO Shipping Holdings Co Ltd
OTC:CICOF
|
CN |
|
D
|
Digital Daesung Co Ltd
KOSDAQ:068930
|
KR |
|
P
|
Pierrel SpA
MIL:PRL
|
IT |
|
FirstEnergy Corp
NYSE:FE
|
US |
|
Corning Inc
SIX:GLW
|
US |
|
ARMOUR Residential REIT Inc
NYSE:ARR
|
US |
|
E
|
Emperor Entertainment Hotel Ltd
HKEX:296
|
HK |
|
K
|
Kawasaki Heavy Industries Ltd
DUS:KHE
|
JP |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is AKYA's stock price target?
Not Available
AKYA does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Akoya Biosciences Inc?
Projected CAGR
13%
Over the last 4 years, the compound annual growth rate for Revenue has been 18%. The projected CAGR for the next 8 years is 13%.